Foundry Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-13,706
| Closed | -$815K | – | 437 |
|
|
2020
Q3 | $815K | Sell |
13,706
-176
| -1% | -$10.5K | 0.04% | 331 |
|
|
2020
Q2 | $969K | Sell |
13,882
-527
| -4% | -$36.8K | 0.05% | 307 |
|
|
2020
Q1 | $654K | Hold |
14,409
| – | – | 0.04% | 326 |
|
|
2019
Q4 | $937K | Sell |
14,409
-343
| -2% | -$22.3K | 0.04% | 325 |
|
|
2019
Q3 | $916K | Sell |
14,752
-34
| -0.2% | -$2.11K | 0.04% | 322 |
|
|
2019
Q2 | $1.05M | Sell |
14,786
-43
| -0.3% | -$3.06K | 0.04% | 313 |
|
|
2019
Q1 | $1.16M | Buy |
14,829
+2,455
| +20% | +$193K | 0.05% | 310 |
|
|
2018
Q4 | $1.05M | Buy |
+12,374
| New | +$1.05M | 0.05% | 315 |
|